J. Birkenhäger

A. Hofman, D. Grobbee, P. V. van Daele, 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Triglyceride turnover in severe chronic non-nephrotic renal failure.

J. Birkenhäger, L. Verschoor, R. Lammers, 1978, Metabolism: clinical and experimental.

Longitudinal changes in ultrasound parameters of the calcaneus

A. Hofman, D. Grobbee, C. Laet, 1997, Osteoporosis International.

The relation between clinical manifestations of polycystic ovary syndrome and β‐cell function

B. Fauser, R. Weber, J. Birkenhäger, 1993, Clinical endocrinology.

Growth hormone normalizes low-density lipoprotein receptor gene expression in hypothyroid rats.

B. Staels, N. Hoogerbrugge, H. Jansen, 1996, Metabolism: clinical and experimental.

Circulating and liver-bound salt-resistant hepatic lipases in the golden hamster.

H. Jansen, J. Birkenhäger, M. Baggen, 1989, Biochimica et biophysica acta.

Inhibition of insulin- and insulin-like growth factor-I-stimulated growth of human breast cancer cells by 1,25-dihydroxyvitamin D3 and the vitamin D3 analogue EB1089.

H. Pols, J. V. van Leeuwen, J. Birkenhäger, 1996, European journal of cancer.

Inhibition of hepatic cholesterol synthesis by the alpha 1-adrenoceptor blocker doxazosin in the hypercholesterolemic golden hamster.

H. Jansen, J. Birkenhäger, J. Penders, 1989, Life sciences.

Growth hormone and thyroxine affect lipoprotein metabolism in hypothyroid and hypophysectomized rats.

H. Jansen, J. Birkenhäger, N. Hoogerbrugge-vd Linden, 1990, The Journal of endocrinology.

Relationship between insulin-like growth factor-I and low-density lipoprotein cholesterol levels in primary hypothyroidism in women.

H. Jansen, J. Birkenhäger, W. C. Hülsmann, 1989, The Journal of endocrinology.

Evidence for Involvement of 17β‐Estradiol in Intestinal Calcium Absorption Independent of 1,25‐Dihydroxyvitamin D3 Level in the Rat

H. Pols, J. V. van Leeuwen, S. Christakos, 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Turnover rate of plasma FFA and rate of esterification of plasma FFA to plasma triglycerides in obese humans before and after weight reduction.

J. Birkenhäger, T. Tjabbes, 1969, Metabolism: clinical and experimental.

Raised plasma intact parathyroid hormone concentrations in young people with mildly raised blood pressure

A. Hofman, D. Grobbee, J. Birkenhäger, 1988, British medical journal.

Calcium and Phosphorus Metabolism, Parathyroid Hormone, Calcitonin and Bone Histology in Pseudohypoparathyroidism *

F. Roelfsema, J. Birkenhäger, W. Hackeng, 1973, European journal of clinical investigation.

Demonstration of a heparin‐releasable liver‐lipase‐like activity in rat adrenals

H. Jansen, C. Kalkman, J. Birkenhäger, 1980, FEBS letters.

Inhibition of breast cancer cell growth by combined treatment with vitamin D3 analogues and tamoxifen.

L. Dorssers, H. Pols, J. Birkenhäger, 1994, Cancer research.

Vitamin D analogues: from molecule to clinical application

H. Pols, J. Birkenhäger, J. Leeuwen, 1994, Clinical endocrinology.

The effects of MC903 on 1,25-(OH)2D3 receptor binding, 24-hydroxylase activity and in vitro bone resorption.

H. Pols, J. V. van Leeuwen, J. Birkenhäger, 1991, Bone and mineral.

Vitamin D: A modulator of cell proliferation and differentiation

J. Foekens, J. Birkenhäger, J. Leeuwen, 1990, The Journal of Steroid Biochemistry and Molecular Biology.

Evidence for uncoupling of bone formation and bone resorption in women with hip fractures: A prospective study

A. Hofman, M. Seibel, C. Laet, 2006, Osteoporosis International.

The value of the thyrotropin-releasing hormone test in patients with prolactin-secreting pituitary tumors and suprasellar non-pituitary tumors.

J. Klijn, F. de Jong, J. Birkenhäger, 1981, Fertility and sterility.

TRH TEST FOR PROLACTINOMA

David Handelsman, D. Yue, J. Turtle, 1979, The Lancet.

Course of bone mass during and after hormonal replacement therapy with and without addition of nandrolone decanoate

H. Pols, C. van Kuijk, J. Birkenhäger, 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Changes in body composition during treatment of obesity by intermittent starvation.

J. Birkenhäger, A. Haak, J. Ackers, 1968, Metabolism: clinical and experimental.

The effect of long-term chlorthalidone on stone formation and stone growth, intestinal absorption of calcium and secretion of parathyroid hormone in idiopathic hypercalciuria.

J. Birkenhäger, J. Lockefeer, J. R. Juttmann, 1977, The Netherlands journal of medicine.

Adjacent genes, for COL2A1 and the vitamin D receptor, are associated with separate features of radiographic osteoarthritis of the knee.

A. Hofman, C. V. van Duijn, C. Duijn, 2000, Arthritis and rheumatism.

Consequences of vitamin D receptor gene polymorphisms for growth inhibition of cultured human peripheral blood mononuclear cells by 1,25‐dihydroxyvitamin D3

H. Pols, J. V. van Leeuwen, A. Uitterlinden, 2000, Clinical endocrinology.

Intestinal calcium absorption, serum phosphate, and parathyroid hormone in patients with chronic renal failure and osteodystrophy before and during hemodialysis

J. Birkenhäger, J. R. Juttmann, J. Hagenouw-Taal, 1978, Calcified Tissue Research.

Growth hormone normalizes hepatic lipase in hypothyroid rat liver.

B. Staels, N. Hoogerbrugge, H. Jansen, 1993, Metabolism: clinical and experimental.

Seasonal fluctuations in serum concentrations of vitamin D metabolites

T. Visser, J. Birkenhäger, J. R. Juttmann, 1982, British medical journal.

Evidence that the self-induced metabolism of 1,25-dihydroxyvitamin D-3 limits the homologous up-regulation of its receptor in rat osteosarcoma cells.

T. Visser, H. Pols, J. Birkenhäger, 1988, Biochimica et biophysica acta.

Vitamin D receptor genotype is associated with radiographic osteoarthritis at the knee.

A. Hofman, C. Duijn, E. Odding, 1997, The Journal of clinical investigation.

Bone mass in women with primary biliary cirrhosis: the relation with histological stage and use of glucocorticoids.

H. Pols, J. Birkenhäger, P. Kooij, 1990, Gastroenterology.

Asymptomatic primary hyperparathyroidism.

R. Bouillon, J. Birkenhäger, 1996, Postgraduate medical journal.

Conformational change and enhanced stabilization of the vitamin D receptor by the 1,25-dihydroxyvitamin D3 analog KH1060.

H. Pols, J. V. van Leeuwen, J. Birkenhäger, 1996, Proceedings of the National Academy of Sciences of the United States of America.

Different causes for hypertriglyceridemia in male and female patients with chronic renal failure?

H. Jansen, J. Birkenhäger, L. Verschoor, 1983, The Journal of clinical endocrinology and metabolism.

The effect of Synacthen administration on lipoprotein lipase activity in the epididymal fat pad of the rat.

H. Jansen, J. Birkenhäger, M. Baggen, 1985, Metabolism: clinical and experimental.

The mechanism of the potentiating effect of glucocorticoids on catecholamine-induced lipolysis.

J. Birkenhäger, S. Lamberts, H. Timmermans, 1975, Metabolism: clinical and experimental.

The mechanism of the suppressive action of bromocriptine on adrenocorticotropin secretion in patients with Cushing's disease and Nelson's syndrome.

J. Klijn, S. Lamberts, F. de Jong, 1980, The Journal of clinical endocrinology and metabolism.

THE ROLE OF DOPAMINERGIC DEPLETION IN THE PATHOGENESIS OF CUSHING'S DISEASE AND THE POSSIBLE CONSEQUENCES FOR MEDICAL THERAPY

J. Birkenhäger, S. Lamberts, F. H. Jong, 1977, Clinical endocrinology.

BROMOCRIPTINE IN NELSON'S SYNDROME AND CUSHING'S DISEASE

J. Birkenhäger, S. Lamberts, 1976, The Lancet.

Effect of bromocriptine in pituitary-dependent Cushing's syndrome.

J. Birkenhäger, S. Lamberts, 1976, The Journal of endocrinology.

Vitamin D receptor gene polymorphisms and osteoporosis

A. Uitterlinden, H. Pols, J. Birkenhäger, 1996, Steroids.

[Fractures of the proximal end of the femur].

B. van Linge, J. Birkenhäger, 1982, Nederlands tijdschrift voor geneeskunde.

Body composition in Cushing's disease.

J. Birkenhäger, S. Lamberts, 1976, The Journal of clinical endocrinology and metabolism.

SERUM CONCENTRATIONS OF METABOLITES OF VITAMIN D IN PATIENTS WITH CHRONIC RENAL FAILURE (CRF). CONSEQUENCES FOR THE TREATMENT WITH 1‐α‐HYDROXY‐DERIVATIVES

T. Visser, J. Birkenhäger, C. Buurman, 1981, Clinical endocrinology.

Calcium and glucose uptake in rat small intestinal brush-border membrane vesicles. Modulation by exogenous hypercortisolism and 1,25-dihydroxyvitamin D-3.

H. D. de Jonge, J. Birkenhäger, H. Jonge, 1984, Biochimica et biophysica acta.

INFLUENCE OF 1α‐(OH)D3 ADMINISTRATION ON BONE AND BONE MINERAL METABOLISM IN PATIENTS ON CHRONIC GLUCOCORTICOID TREATMENT; A DOUBLE BLIND CONTROLLED STUDY

T. Visser, J. Birkenhäger, A. Rietveld, 1983, Clinical endocrinology.

The influence of albumin on vitamin D metabolism in fetal chick osteoblast-like cells.

P. Nijweide, T. Visser, H. Pols, 1984, Biochemical and biophysical research communications.

Depressed plasma FFA turnover rate in Cushing's syndrome.

J. Birkenhäger, S. Lamberts, H. Timmermans, 1976, The Journal of clinical endocrinology and metabolism.

Follow-up of long-term treatment of predialysis renal bone disease with 1-alpha-hydroxy-derivatives of vitamin D.

T. Visser, C. van Krimpen, J. Birkenhäger, 1983, Journal of steroid biochemistry.

A study on the phalanx bone mineral content in 273 normal pre- and post-menopausal females (transverse study of age-dependent bone loss).

J. Birkenhäger, A. Drogendijk, W. Trouerbach, 1987, Bone and mineral.

Bone changes associated with glucocorticoid excess.

J. Birkenhäger, A. van Seters, D. Smeenk, 1967, Proceedings of the Royal Society of Medicine.

Seasonal fluctuations in serum concentrations of vitamin D metabolites in normal subjects.

T. Visser, J. Birkenhäger, C. Buurman, 1981 .

Bidirectional regulation of the 1,25-dihydroxyvitamin D3 receptor by phorbol ester-activated protein kinase-C in osteoblast-like cells: interaction with adenosine 3',5'-monophosphate-induced up-regulation of the 1,25-dihydroxyvitamin D3 receptor.

H. Pols, J. V. van Leeuwen, J. Birkenhäger, 1992, Endocrinology.

Heterologous up-regulation of the 1,25-dihydroxyvitamin D3 receptor by parathyroid hormone (PTH) and PTH-like peptide in osteoblast-like cells.

T. Visser, H. Pols, J. V. van Leeuwen, 1988, Biochemical and biophysical research communications.

THE IMPORTANCE OF PITUITARY TUMOUR SIZE IN PATIENTS WITH HYPERPROLACTINAEMIA IN RELATION TO HORMONAL VARIABLES AND EXTRASELLAR EXTENSION OF TUMOUR

J. Klijn, S. Lamberts, R. Docter, 1980, Clinical endocrinology.

Transforming growth factor β-induced dissociation between vitamin D receptor level and 1,25-dihydroxyvitamin D3 action in osteoblast-like cells

H. Pols, A. Staal, J. Birkenhäger, 1994 .

Evidence for coordinated regulation of osteoblast function by 1,25-dihydroxyvitamin D3 and parathyroid hormone.

H. Pols, J. V. van Leeuwen, J. Birkenhäger, 1996, Biochimica et biophysica acta.

Parathyroid hormone sensitizes long bones to the stimulation of bone resorption by 1,25‐dihydroxyvitamin D3

J. V. van Leeuwen, J. Birkenhäger, H. Pols, 1992, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Growth hormone restores hepatic lipase mRNA levels but the translation is impaired in hepatocytes of hypothyroid rats.

N. Hoogerbrugge, A. Verhoeven, H. Jansen, 1997, Biochimica et biophysica acta.

Effects of synacthen on lipid metabolism in the perfused epididymal fat pad of the rat.

H. Jansen, J. Birkenhäger, L. Verschoor, 1987, Metabolism: clinical and experimental.

Medullary thyroid carcinoma: ectopic production of peptides with ACTH-like, corticotrophin releasing factor-like and prolactin production-stimulating activities.

D. Krieger, A. Tashjian, J. Birkenhäger, 1976, Acta endocrinologica.

Combined effects of 1,25-dihydroxyvitamin D3 and tamoxifen on the growth of MCF-7 and ZR-75-1 human breast cancer cells

H. Pols, J. Birkenhäger, J. Leeuwen, 2004, Breast Cancer Research and Treatment.

Distinct conformations of vitamin D receptor/retinoid X receptor-alpha heterodimers are specified by dinucleotide differences in the vitamin D-responsive elements of the osteocalcin and osteopontin genes.

G. Stein, J. Lian, H. DeLuca, 1996, Molecular endocrinology.

Modulation by epidermal growth factor of the basal 1,25(OH)2D3 receptor level and the heterologous up-regulation of the 1,25(OH)2D3 receptor in clonal osteoblast-like cells

T. Visser, H. Pols, J. Birkenhäger, 2007, Calcified Tissue International.

Association of radiographically evident osteoarthritis with higher bone mineral density and increased bone loss with age. The Rotterdam Study.

A. Hofman, H. Valkenburg, D. Grobbee, 1996, Arthritis and rheumatism.

Properties of antisera against synthetic 1--34 human parathyroid hormone.

T. Visser, J. Birkenhäger, W. Hackeng, 1975, The Journal of endocrinology.

An energy‐dependent corticosterone uptake system in the rat liver cell

J. Birkenhäger, S. Lamberts, G. Jonkers, 1980, FEBS letters.

Causes of failure in operations for hyperparathyroidism.

H. Bruining, S. Lamberts, J. Birkenhäger, 1987, Surgery.

Parathyroid hormone secretion in disorders of calcium metabolism studied by means of EDTA.

J. Birkenhäger, W. Hackeng, J. Lockefeer, 1974, Acta endocrinologica.

Danazol in the treatment of endometriosis and hereditary angio-oedema.

N. Hoogerbrugge, H. Jansen, J. Birkenhäger, 1995, Journal of internal medicine.

Transient bitemporal hemianopsia during pregnancy after treatment of galactorrhea-amenorrhea syndrome with bromocriptine.

J. Birkenhäger, S. Lamberts, H. G. Kwa, 1977, The Journal of clinical endocrinology and metabolism.

Results of operative treatment of 615 patients with primary hyperparathyroidism

H. Bruining, S. Lamberts, J. Birkenhäger, 2005, World Journal of Surgery.

Age‐associated changes in ultrasound measurements of the calcaneus in men and women: The rotterdam study

A. Hofman, D. Grobbee, P. V. van Daele, 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Hormone secretion in alcohol-induced pseudo-Cushing's syndrome. Differential diagnosis with Cushing disease.

J. Klijn, F. de Jong, J. Birkenhäger, 1979, JAMA.

The incidence of complications during pregnancy after treatment of hyperprolactinemia with bromocriptine in patients with radiologically evident pituitary tumors.

J. Klijn, J. Birkenhäger, S. Lamberts, 1979, Fertility and sterility.

Value of luteinizing hormone-releasing hormone testing in bromocriptine treatment of amenorrhea and hyperprolactinemia in patients with pituitary tumors.

F. de Jong, R. Docter, J. Birkenhäger, 1978, Fertility and sterility.

Evaluation of a therapeutic regimen in Cushing's disease. The predictability of the result of unilateral adrenalectomy followed by external pituitary irradiation.

F. de Jong, J. Birkenhäger, S. Lamberts, 1977, Acta endocrinologica.

A comparative study of two methods of measurement of fractional calcium absorption: results in normal individuals and patients with various disturbances of calcium metabolism

J. Birkenhäger, J. Lockefeer, J. R. Juttmann, 1978, European journal of clinical investigation.

Evaluation of diagnostic and differential diagnostic tests in Cushing's syndrome.

F. de Jong, J. Birkenhäger, S. Lamberts, 1977, The Netherlands journal of medicine.

The recovery of the hypothalamo-pituitary-adrenal axis after transsphenoidal operation in three patients with Cushing's disease. The effect of prior external pituitary irradiation.

J. Birkenhäger, S. Lamberts, J. de Jong, 1981, Acta endocrinologica.

24,25-dihydroxyvitamin D, (24,25-) appears to favour cortical bone mass in renal bone disease

H. Pols, A. Nigg, J. Birkenhäger, 1992 .

1α-HYDROXYCHOLECALCIFEROL IN CHRONIC RENAL FAILURE

J. Birkenhäger, D. Birkenhäger-Frenkel, 1976, The Lancet.

A longitudinal study of bone-mineral content and intestinal calcium absorption in patients with chronic renal failure.

J. Birkenhäger, J. R. Juttmann, J. Hagenouw-Taal, 1979, Metabolism: clinical and experimental.

A large‐scale population‐based study of the association of vitamin D receptor gene polymorphisms with bone mineral density

A. Hofman, A. Uitterlinden, C. V. van Duijn, 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Virilization of the voice in post-menopausal women due to the anabolic steroid nandrolone decanoate (Decadurabolin). The effects of medication for one year.

M. Brocaar, J. Birkenhäger, M. Hakkesteegt, 1994, Clinical otolaryngology and allied sciences.

Autoantibodies against malondialdehyde-modified LDL are elevated in subjects with an LDL subclass pattern B.

H. Jansen, J. Birkenhäger, H. Ghanem, 1995, Atherosclerosis.

Antagonistic effects of transforming growth factor-beta on vitamin D3 enhancement of osteocalcin and osteopontin transcription: reduced interactions of vitamin D receptor/retinoid X receptor complexes with vitamin E response elements.

G. Stein, J. Lian, H. DeLuca, 1996, Endocrinology.

Antiestrogens inhibit in vitro bone resorption stimulated by 1,25-dihydroxyvitamin D3 and the vitamin D3 analogs EB1089 and KH1060.

H. Pols, J. V. van Leeuwen, J. Birkenhäger, 1995, Endocrinology.

A cross-sectional study of age-related loss of mineral content of phalangeal bone in men and women

P. Schmitz, H. Collette, J. Birkenhäger, 2004, Skeletal Radiology.

Noninvasive axial and peripheral assessment of bone mineral content: A comparison between osteoporotic women and normal subjects

T. Stijnen, H. Pols, J. Birkenhäger, 1989, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

The treatment of Cushing's disease.

F. de Jong, J. Birkenhäger, S. Lamberts, 1980, The Netherlands journal of medicine.

Regulation of Osteocalcin Production and Bone Resorption by 1,25‐Dihydroxyvitamin D3 in Mouse Long Bones: Interaction with the Bone‐Derived Growth Factors TGF‐β and IGF‐I

J. V. van Leeuwen, A. Staal, J. Birkenhäger, 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Role of calcium and cAMP in heterologous up-regulation of the 1,25-dihydroxyvitamin D3 receptor in an osteoblast cell line.

H. Pols, J. V. van Leeuwen, J. Birkenhäger, 1990, Cell calcium.

Production and characterization of antisera to synthetic 1-34 human parathyroid hormone fragments: possible implications for the correctness of proposed structures.

T. Visser, J. Birkenhäger, C. Buurman, 1979, Acta endocrinologica.

Regulation of 1,25-dihydroxyvitamin D3 receptor gene expression by parathyroid hormone and cAMP-agonists.

H. Pols, J. V. van Leeuwen, J. Birkenhäger, 1992, Biochemical and biophysical research communications.

Functional involvement of calcium in the homologous up‐regulation of the 1,25‐dihydroxyvitamin D3 receptor in osteoblast‐like cells

J. V. van Leeuwen, J. Birkenhäger, H. Pols, 1990, FEBS letters.

Consequences of vitamin D receptor regulation for the 1,25-dihydroxyvitamin D3-induced 24-hydroxylase activity in osteoblast-like cells: initiation of the C24-oxidation pathway.

H. Pols, J. V. van Leeuwen, A. Staal, 1997, Bone.

The effects of 1,25-dihydroxyvitamin D3 on growth, alkaline phosphatase and adenylate cyclase of rat osteoblast-like cells.

T. Visser, H. Pols, J. Birkenhäger, 1986, Bone and mineral.